Efficacy of HCV core antigen detection during the preseroconversion period. - Wikidata - wikimedia - TriplyDB

Efficacy of HCV core antigen detection during the preseroconversion period.

Efficacy of HCV core antigen detection during the preseroconversion period.

http://www.wikidata.org/entity/Q43000848

about

Usefulness of the Hepatitis C Virus Core Antigen Assay for Screening of a Population Undergoing Routine Medical Checkup Simultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV Infection Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.Hepatitis C virus infection: early diagnosis and identification of response to antiviral therapy.Evaluation of an antigen-antibody "combination" enzyme linked immunosorbent assay for diagnosis of hepatitis C virus infections.Use and interpretation of virological tests for hepatitis C.Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV results Detection of hepatitis C virus core antigen in blood donors using a new enzyme immunoassay.Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples SASLT practice guidelines: management of hepatitis C virus infection.Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction.Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.Hepatitis C virus and kidney: a strong association with different clinical aspects.Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?Current testing strategies for hepatitis C virus infection in blood donors and the way forward A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.Estimated risk of transfusion-transmitted viral infections in Spain.Core antigen tests for hepatitis C virus: a meta-analysis.Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.Detection of free hepatitis C virus core antigen by enzyme-linked immunosorbent assay is not suitable for screening of granulocyte colony-stimulating factor-mobilized hematopoietic progenitor donors.Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies.Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?Detection of HCV core antigen in HCV RNA positive, anti-HCV negative blood donations from Polish blood donors.Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.HCV core antigen assay.High-throughput HBV DNA and HCV RNA detection system using a nucleic acid purification robot and real-time detection PCR: its application to analysis of posttransfusion hepatitis.Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay.Acute nosocomial HCV infection detected by NAT of a regular blood donor.Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion.Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase.Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.

P2860

Q27469465-9822B972-4AE1-46F1-9E92-BE1AA3A7D323 Q27471998-9E8B1B2B-3C83-4CB3-AA47-E393FB61EAEF Q30342718-93CEBCF1-4963-4BD9-A3F3-9A3E793B03AF Q31050666-136A2B1E-930D-45CF-8D73-E57491685D21 Q33450364-E0923425-F29E-4F51-B102-2A9E35B83B16 Q33592762-6332F897-62CA-4979-A0D2-07D8ACC49F87 Q34100073-CB91F898-9751-42F0-A2B3-53D45AAD59A3 Q34569308-7FB07B61-15A3-4DB1-B996-C5D44E7A4963 Q34588996-23EA00F5-4DE2-4B46-A7E9-9F3CBD0301E8 Q34984049-5F5A8AEE-704F-4FD4-8CC4-2F838556BB25 Q35599069-2246D5EB-AAF6-490A-B272-D71C48EF3D48 Q36133920-D867C320-3C2D-4A04-8327-1BEA921EEFA0 Q36554189-CBEC99CC-7196-428E-B8E4-E001E91017B7 Q37019765-8D38D97F-E6A7-43C4-8DD7-FE97487CB800 Q37158806-CF4C01F4-FBA1-43A0-A187-196F18D257CB Q37296858-59363C13-5B5D-4893-A79F-21DCCD94D5FC Q37899933-57385DD0-49AA-4BCD-8358-F2D6F7CFCF40 Q37961619-97388066-EA53-40F2-8E8D-958D3BF36FBE Q38198619-12DED2A7-7D0A-400F-AD59-930D8FA29C27 Q38883263-161EDC19-DEF1-4B41-9FA9-8B8E6EEB9469 Q39321794-C964376A-7ED7-48DE-93D1-0F82A3B9FE99 Q39466003-A8A3A275-D669-4DD6-BC54-3BABBE05D99F Q39559479-B3AA1E6D-E290-4A79-B7AC-E3BE9F86BC7B Q40626774-37095D82-FAB8-4BE4-BDF0-541E077C7FF0 Q42979904-2C13BFC8-118D-4A96-9FAD-60B6A66BAF90 Q42984995-F6568CA9-7228-424D-B9D3-57D8D50F126B Q42989343-0BB70967-98CB-4D9C-8F4D-383AD023EF04 Q42994597-180CC9DD-2F49-4A0F-841F-06D76BAFC467 Q42997213-DD941BE1-08C8-4548-91EA-2E657088CDDA Q42997289-4A6B2EAC-ECEF-4429-8BCE-271C6C9745E3 Q43030236-7869D6C0-4530-4BD6-810B-ED2F7EE5CDA1 Q43031733-98567858-1EAA-418E-BB32-5BBA319F7765 Q43034238-80FCCF56-CD0C-4B3E-B437-F9A5489D2B8E Q43037058-AE688D42-DC18-4CFA-8EA1-F977A47CE874 Q43037481-603180BE-1586-4598-A5CB-2C942138267C Q43039282-09042447-E10D-4F41-A82D-9F1EAEFDDFDB Q43040539-439445A2-D15B-4E13-8198-686348255588 Q43040540-C07AAF5F-5751-493C-B45C-55EFB3250FC4 Q43042208-8571A535-294A-41D1-8904-170BB4464858 Q43047661-1C5B58E6-1FBC-4050-A722-7C3F498E3364

P2860

Efficacy of HCV core antigen detection during the preseroconversion period.

http://www.wikidata.org/entity/Q43000848

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh-hant

name

Efficacy of HCV core antigen detection during the preseroconversion period.

@en

Efficacy of HCV core antigen detection during the preseroconversion period.

@nl

type

label

Efficacy of HCV core antigen detection during the preseroconversion period.

@en

Efficacy of HCV core antigen detection during the preseroconversion period.

@nl

prefLabel

Efficacy of HCV core antigen detection during the preseroconversion period.

@en

Efficacy of HCV core antigen detection during the preseroconversion period.

@nl

P1433

Q43000848-430AD939-96EA-4D9F-9CE9-2371BD0DAA9E

P1476

Q43000848-900802A0-C8C6-4A81-8E3D-85ECA7BCE472

P2093

Q43000848-5517B500-5BEC-4ECA-BE1C-C8AE32DD9DD7

Q43000848-AE11ABDB-42A9-490C-969C-FDFEEF4E0EF5

Q43000848-B4F9F081-A4D7-403A-B193-295F7D8B4456

Q43000848-D8DEE12C-B99B-4AEB-9FF7-F392F4940BDE

Q43000848-DA2C8079-A096-4EC3-A8B3-760B20661E1F

Q43000848-DE778036-98A2-486B-B9BF-BAFD3923D0CC

Q43000848-E9817DE0-9E69-4521-B7EB-EAA50B74D101

P2860

Q43000848-1B9D00F4-121E-4578-8875-50353EC3FBE1

Q43000848-236E4C92-CB92-4D12-85C1-A6DBE9E80014

Q43000848-4527F4AA-CF59-45FF-8B50-350B4762E5F4

Q43000848-540BC109-4CC2-4148-AA03-D2F9B4AC1972

Q43000848-66295D1C-AC00-49F0-9402-5C2DDF55D526

Q43000848-71C6BC8D-463E-439F-9819-54266F828253

Q43000848-89DCFCC8-74C2-437E-A748-61DEFF265AA3

Q43000848-AAEDD96F-CE3F-49C4-B8CE-993CE2BB0CB4

Q43000848-BBF86AFE-3B63-4F04-A707-0258B91EF9A4

Q43000848-F67CAC57-1EDE-4E84-A848-95D3F4124B81

P304

Q43000848-1F5F39FD-C5AE-4E4B-A524-3EA41DBB5FE5

P31

Q43000848-00F8EFEB-CA4A-4C00-8B54-54828747F875

P356

Q43000848-4D14ECFF-FB01-4FDB-B3EA-DB28EFE1E0F5

P433

Q43000848-65A410E7-E59A-4A2D-BD62-649786D22A21

P478

Q43000848-FDE654E5-0F35-4066-BD0E-704590E0BF61

P577

Q43000848-ACEB6B09-A93E-4531-9F56-04EB773EBE79

P698

Q43000848-278C3A4F-65DB-4724-B9C2-DEFBF3D0ECE3

P356

J.1537-2995.2000.40101198.X

P1433

P1476

Efficacy of HCV core antigen detection during the preseroconversion period.

@en

P2093

Bouchardeau F

http://www.w3.org/2001/XMLSchema#string

Couroucé AM

http://www.w3.org/2001/XMLSchema#string

Laperche S

http://www.w3.org/2001/XMLSchema#string

Le Marrec N

http://www.w3.org/2001/XMLSchema#string

Maniez M

http://www.w3.org/2001/XMLSchema#string

Razer A

http://www.w3.org/2001/XMLSchema#string

Simon N

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence analysis of the core gene of 14 hepatitis C virus genotypes

Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes.

Risk-benefit analysis of nucleic acid testing: the French experience.

Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection.

Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA.

A twelve year natural history of hepatitis C virus infection in hemodialyzed patients.

Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA).

Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays.

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.

P304

1198-1202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1537-2995.2000.40101198.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2000-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11061855

http://www.w3.org/2001/XMLSchema#string